Androsin

Androsin

SCHEMBL29655138

COc1cc(C(C)=O)ccc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.68
SNCA P37840 1/20 0.65
PTGS1 P23219 1/20 0.61
DYRK1A Q13627 1/20 0.58
CA12 O43570 2/20 0.57
CA1 P00915 2/20 0.57
CA9 Q16790 2/20 0.57
CA7 P43166 1/20 0.57
CA13 Q8N1Q1 1/20 0.57
SLC28A3 Q9HAS3 4/20 0.57
TYR P14679 1/20 0.56
KDM4E B2RXH2 1/20 0.55
POLB P06746 1/20 0.55
GAA P10253 1/20 0.55
RECQL P46063 1/20 0.55
LMNA P02545 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
MGAM O43451 1/20 0.53
CA2 P00918 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Androsin SCHEMBL19590975 1.00 ACHE (0.68) ACHESNCAPTGS1DYRK1ACA12
Androsin SCHEMBL8977517 1.00 ACHE (0.68) ACHESNCAPTGS1DYRK1ACA12
Androsin SCHEMBL8977518 1.00 ACHE (0.68) ACHESNCAPTGS1DYRK1ACA12
Androsin SCHEMBL464790 1.00 ACHE (0.68) ACHESNCAPTGS1DYRK1ACA12
Androsin SCHEMBL8977529 1.00 ACHE (0.68) ACHESNCAPTGS1DYRK1ACA12
Androsin SCHEMBL8977521 1.00 ACHE (0.68) ACHESNCAPTGS1DYRK1ACA12
SCHEMBL19798068 0.90 ACHE (0.68) ACHESNCAPTGS1DYRK1ACA12
SCHEMBL2910488 0.90 ACHE (0.68) ACHESNCAPTGS1DYRK1ACA12
SCHEMBL19798066 0.89 SNCA (0.67) ACHESNCAPTGS1CA12CA1
Glucoacetosyringone SCHEMBL8977542 0.86 PTGS1 (0.64) ACHESNCAPTGS1DYRK1ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026003700-A1 PROCESS FOR RECYCLING SOLVENT AND DRYING SODIUM SALTS OF FATTY ACIDS AND ROSIN ACIDS FROM CRUDE TALL OIL STORA ENSO OYJ (FI) 2026-01-02 WO disclosed
WO-2025248168-A1 METHOD FOR PRODUCING DISPERSION COMPRISING POLYSACCHARIDE AND ROSIN AND DISPERSION THEREOF KEMIRA OYJ (FI) 2025-12-04 WO disclosed
US-12325646-B2 Fertigation water treatment UNIVERSITY OF GUELPH (CA) 2025-06-10 US disclosed
CN-118667511-A Wax-based hot melt adhesive for denture processing and preparation method thereof 珠海拜瑞科技有限公司 2024-09-20 CN disclosed
US-20240108040-A1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2024-04-04 US disclosed
CN-117415515-A Low-void-ratio halogen-free soldering paste, soldering paste and preparation method thereof 有研纳微新材料(北京)有限公司 2024-01-19 CN disclosed
US-11814557-B2 Fatty acid and rosin acid ester compositions for use as plasticizers in adhesive formulations and associated methods of use INGEVITY SOUTH CAROLINA, LLC (US) 2023-11-14 US disclosed
US-11758933-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2023-09-19 US disclosed
CN-111349397-B Pale rosin and rosin ester compositions 科腾聚合物有限责任公司 2023-09-12 CN disclosed
US-20230220205-A1 WAX-LIKE FORMULATIONS OF NATURAL-ORIGIN MATERIALS AND ITS METHOD OF PREPARATION IND ALEN S A DE C V (MX) 2023-07-13 US disclosed
EP-4157906-A1 WAX-LIKE FORMULATIONS OF NATURAL-ORIGIN MATERIALS AND ITS METHOD OF PREPARATION Industrias Alen, S.A. de C.V. (MX) 2023-04-05 EP disclosed
CN-218602083-U Huqin with magnetic attraction function 黄自刚 2023-03-10 CN disclosed
CN-218602083-U Huqin with magnetic attraction function 黄自刚 2023-03-10 CN disclosed
US-20230028097-A1 FATTY ACID AND ROSIN ACID ESTER COMPOSITIONS FOR USE AS PLASTICIZERS IN ADHESIVE FORMULATIONS AND ASSOCIATED METHODS OF USE MAINSTREAM PINE PRODUCTS, LLC 2023-01-26 US disclosed
US-20220234916-A1 WATER TREATMENT UNIVERSITY OF GUELPH (CA) 2022-07-28 US disclosed
EP-3368542-B1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2022-06-22 EP disclosed
US-11357246-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2022-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108040-A1 HIGH INTENSITY SWEETENERS TAS2R40, TAS2R60, TAS1R1 ACHE 505/4885SNCA 2674/4885PTGS1 1786/4885
US-11357246-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 ACHE 505/4885SNCA 2674/4885PTGS1 1786/4885
US-11758933-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 ACHE 505/4885SNCA 2674/4885PTGS1 1786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.